Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation

In patients with symptomatic COPD, severe/very severe airflow limitation, and a history of one moderate (and no severe) exacerbation, ICS-containing triple therapy significantly reduces exacerbation risk overall versus single or double maintenance therapy http://ow.ly/VgJC30o9pXC

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Singh, Dave, Fabbri, Leonardo M., Corradi, Massimo, Georges, George, Guasconi, Alessandro, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2019
Assuntos:
Agora
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853799/
https://ncbi.nlm.nih.gov/pubmed/30792343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00235-2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados